FOXO1 and acute myeloid leukemia: However, other researchers found that FOXO1 promoted resistance of non-Hodgkin lymphomas to anti-CD20-based therapy and played a tumor-promoting role in FLT3-ITD+ AML through a complex mechanism, respectively [17,18].